Delivery Order SPE2DB20D1100-SPE2DB24FC7M5

Award Date 7/15/24
Potential Completion Date 8/5/24
Potential Value $13K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The Defense Logistics Agency (DLA) awarded a delivery order contract valued at $1,259.50 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 400 mg vials of BENLYSTA, a pharmaceutical product. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical through December 31, 2025. The IDC enables DLA to efficiently procure a range of pharmaceutical products and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,628.98, is a delivery order for the medication BENLYSTA 400 MG VIALS. The contract is a firm-fixed price arrangement with a completion date of June 5, 2025. AmerisourceBergen Drug Corp is the prime contractor, and there is no indication of any major subcontractors. This contract is not set...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract to AmerisourceBergen Drug Corp's Corporate Office division, valued at $5,038.00, for the delivery of 400 mg vials of the pharmaceutical drug BENLYSTA. This Firm Fixed Price contract has a completion date of July 2, 2024. AmerisourceBergen is a major supplier of pharmaceuticals and medical supplies to the federal government, with an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with DLA Troop Support...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of BENLYSTA 400 MG VIALS to the Defense Logistics Agency (DLA). The contract, valued at $11,213.60, is a firm fixed price delivery order with a period of performance through July 11, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of BENLYSTA 400 MG VIALS. The $5,038.00 firm fixed price contract has a period of performance through November 4, 2024. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this order as part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with DLA Troop Support Medical to provide a comprehensive range of medical commodities supporting...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the provision of BENLYSTA 400 MG VIALS, a pharmaceutical product. The contract has a total ceiling value of $5,038.00 and is structured as a firm fixed price delivery order with a period of performance through June 18, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The contract, valued at $5,796.40, is for the supply of BENLYSTA 400 MG vials, a specialty pharmaceutical product, under a Firm Fixed Price arrangement. The delivery order has an ultimate completion date of August 30, 2024. Amerisourcebergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with federal agencies,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 400 mg vials of the drug Benlysta, with a ceiling value of $13,148.10 and a performance period through May 16, 2025. The contract is a firm fixed-price delivery order and is not set aside for any particular business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,777.72 firm fixed-price delivery order is for BENLYSTA 400 MG VIALS, with a completion date of June 6, 2025. The contract is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The $1,516.80 firm fixed price contract is for the delivery of 120 mg vials of the prescription medication BENLYSTA. The contract has no set-aside designation and will run through June 6, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at up to $999,999,999.00 through December 31, 2025. This...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FC7M5
    Delivery Order

This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office Division. The contract, valued at $12,595.00, is for the delivery of BENLYSTA 400 MG VIALS, a pharmaceutical product. The contract has no set-aside designation and is a Firm Fixed Price contract.

AmerisourceBergen Drug Corp, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for AmerisourceBergen to deliver a wide range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. The company also holds a smaller IDC with the Department of Justice Federal Bureau of Investigation for similar medical products and prescription drugs, valued up to $750,000 through May 2024.

Generated 10/14/24, 10:02 AM